Press release
Global Gene Therapy Market to reach USD USD 34,933.71 million at a CAGR of 19.25% by 2032, Evaluates DelveInsight
DelveInsight's "Gene Therapy Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Gene Therapy companies actively working in the market.
To know more about why North America is leading the market growth in the Gene Therapy market, get a snapshot of the report Gene Therapy Market Trends
https://www.delveinsight.com/sample-request/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Gene Therapy Overview
Gene therapy is a medical approach that involves altering or manipulating a person's genes to treat or prevent diseases. It works by replacing, inactivating, or introducing genes into a patient's cells to correct genetic disorders, fight certain cancers, or address other conditions caused by defective genes. Gene therapy can be delivered using viral or non-viral vectors, and it holds the potential for long-lasting or even permanent therapeutic effects. This approach is considered a cutting-edge treatment option, especially for rare genetic disorders, some cancers, and inherited conditions.
DelveInsight Analysis: The global gene therapy market size was valued at approximately USD 8,570.28 million in 2024 and is projected to grow at a CAGR of 19.25% from 2025 to 2032, reaching around USD 34,933.71 million by the end of the forecast period.
Gene Therapy Market Insights
Geographically, North America is projected to hold the largest share of the global gene therapy market in 2024 among all regions. This dominance is driven by the region's advanced healthcare infrastructure, strong R&D ecosystem, and significant financial investments in cutting-edge biopharmaceuticals. The growing prevalence of rare and genetic disorders, coupled with the presence of major players such as Biogen, Novartis, and PTC Therapeutics, further enhances its market position. Additionally, supportive government initiatives, favorable reimbursement frameworks, and a robust clinical trial pipeline-especially in the United States-are fueling regional growth. The increasing adoption of advanced gene therapy technologies and the higher burden of genetic diseases continue to reinforce North America's leadership in the global market.
To read more about the latest highlights related to Gene Therapy, get a snapshot of the key highlights entailed in the Gene Therapy Market Insights
https://www.delveinsight.com/report-store/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Gene Therapy Market Report
• In November 2024, PTC Therapeutics announced FDA approval of AADC deficiency gene therapy with the brand name KEBILIDITM (eladocagene exuparvovec-tneq), indicated for the treatment of children and adults with AADC deficiency.
• In June 2023, Sarepta Therapeutics, Inc. announced that the U.S. FDA granted accelerated approval for ELEVIDYS (delandistrogene moxeparvovec-rokl), a gene therapy for ambulatory pediatric patients aged 4 to 5 years with Duchenne muscular dystrophy (DMD) who have a confirmed mutation in the DMD gene.
• Thus, owing to such developments in the market, rapid growth will be observed in the Gene Therapy market during the forecast period
Key Players in the Gene Therapy Market
Some of the key market players operating in the Gene Therapy market include- Abiomed, Inc., Asahi Kasei Corporation, Abbott Laboratories, Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC, Cardiobridge Gmbhand, LivaNova, Inc., Cirtec, CorWave SA, FineHeart, ReliantHeart Inc., and Others.
Which MedTech key players in the Gene Therapy market are set to emerge as the trendsetter explore @ Key Gene Therapy Companies
https://www.delveinsight.com/sample-request/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Gene Therapy Market Landscape
Moreover, the growing number of strategic initiatives among leading market players continues to propel the viral gene therapy segment forward. For example, in July 2022, PTC Therapeutics, Inc. received marketing authorization from the European Commission for UpstazaTM (eladocagene exuparvovec)-the first disease-modifying therapy for aromatic L-amino acid decarboxylase (AADC) deficiency and the first gene therapy administered directly into the brain. Designed for patients aged 18 months and older, Upstaza is an AAV2-based gene therapy incorporating the human DDC gene through recombinant technology.
These advancements, along with ongoing innovation, are expected to significantly strengthen the viral gene therapy segment and contribute to the overall growth of the global gene therapy market.
Scope of the Gene Therapy Market Report
• Coverage: Global
• Study Period: 2022-2032
• Gene Therapy Market Segmentation By Vector Type: Viral and Non-Viral
• Gene Therapy Market Segmentation By Delivery Type: Ex Vivo and In Vivo
• Gene Therapy Market Segmentation By Indication: Neurological, Oncological, Hematological, Ophthalmological, and Others
• Gene Therapy Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Gene Therapy Companies: Abiomed, Inc., Asahi Kasei Corporation, Abbott Laboratories, Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC, Cardiobridge Gmbhand, LivaNova, Inc., Cirtec, CorWave SA, FineHeart, ReliantHeart Inc., and Many Others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Gene Therapy market will grow by 2032? Click to get a snapshot of the Gene Therapy Market Analysis
https://www.delveinsight.com/sample-request/gene-therapy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gene Therapy Market to reach USD USD 34,933.71 million at a CAGR of 19.25% by 2032, Evaluates DelveInsight here
News-ID: 4241320 • Views: …
More Releases from DelveInsight Business Research
Global Real-World Evidence Solution Market to reach USD 5,240.07 million at a CA …
According to DelveInsight's analysis, The growth of the real-world evidence (RWE) solutions market is mainly fueled by the rising prevalence of chronic diseases and their significant influence on healthcare outcomes. Moreover, advancements in big data analytics, machine learning, and artificial intelligence are enabling more efficient processing and interpretation of extensive real-world datasets. Additionally, the expanding use of RWE solutions within the pharmaceutical and biotechnology industries-to improve drug development, facilitate regulatory…
Global High Flow Oxygen Therapy Devices Market to grow at a CAGR of 2.31% by 203 …
According to DelveInsight's analysis, The growing incidence of respiratory conditions such as COPD, asthma, pneumonia, and Acute Respiratory Distress Syndrome (ARDS) is fueling the demand for High Flow Oxygen Therapy (HFOT) devices, as healthcare providers increasingly adopt effective non-invasive treatment methods. Additionally, the rise of home healthcare and telemedicine is improving access to HFOT, allowing patients to receive long-term oxygen therapy at home, minimizing hospital visits, and enhancing overall disease…
Autosomal Dominant Optic Atrophy Market Set for Robust Growth Through 2034, Driv …
The autosomal dominant optic atrophy treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and R&D in precision medicine from key pharmaceutical players, including PYC Therapeutics and Stoke Therapeutics, among others.
DelveInsight's "Autosomal Dominant Optic Atrophy - Market Insight, Epidemiology And Market Forecast - 2034" report delivers an in-depth understanding of the ADOA treatment market, historical and forecasted epidemiology, as well as market trends across the US,…
Severe Asthma Market Set for Robust Growth Through 2034, Driven by Breakthrough …
The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key pharmaceutical players, including AstraZeneca, GlaxoSmithKline, Amgen, Teva Pharmaceutical Industries, Novartis, Sanofi, Regeneron Pharmaceutical, Boehringer Ingelheim Pharmaceuticals, Kyorin Pharmaceutical, Pfizer, Chiesi Farmaceutici, AB Science, Avalo Therapeutics, and Theravance Biopharma, among others.
DelveInsight's "Severe Asthma Market Insights, Epidemiology, and Market Forecast-2034" report delivers a comprehensive understanding of the severe asthma…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
